Detailed answers about KERNEXUS MEDICAL COMMUNICATIONS LTD, including incorporation, status, business activity, and accounts information.
When was KERNEXUS MEDICAL COMMUNICATIONS LTD founded?
KERNEXUS MEDICAL COMMUNICATIONS LTD was officially incorporated on 1 December 2025 and is registered under company number 16883925. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is KERNEXUS MEDICAL COMMUNICATIONS LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of KERNEXUS MEDICAL COMMUNICATIONS LTD?
KERNEXUS MEDICAL COMMUNICATIONS LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does KERNEXUS MEDICAL COMMUNICATIONS LTD do?
KERNEXUS MEDICAL COMMUNICATIONS LTD operates in the following sectors: 58142 - Publishing of consumer and business journals and periodicals, 73120 - Media representation services, 82302 - Activities of conference organisers. These SIC codes provide insight into the company's business activities and industry focus.
What is KERNEXUS MEDICAL COMMUNICATIONS LTD's registered address?
The registered office address of KERNEXUS MEDICAL COMMUNICATIONS LTD is FLAT 4 36-38 THICKET ROAD, LONDON, UNITED KINGDOM, SE20 8DD. This is the official address filed with Companies House for legal and statutory correspondence.
Is KERNEXUS MEDICAL COMMUNICATIONS LTD financially stable?
Financial accounts for KERNEXUS MEDICAL COMMUNICATIONS LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.